Answers are grounded in this paper and cite their sources.
Background: Brominated flame retardants (BFRs) are persistent and ubiquitous environmental contaminants with recognized endocrine-disrupting potential, raising concern regarding their possible contribution to human carcinogenesis. This systematic review, conducted in accordance with the PRISMA guidelines, evaluated the association between BFR exposure and human cancer risk, examined the underlying mechanistic pathways, and identified existing research gaps. Methods: A comprehensive literature search of PubMed, Scopus, and EBSCO Discovery Service was performed for studies published between January 2015 and May 2025. Results: Of 752 records identified, 21 studies satisfied the eligibility criteria, comprising eight human epidemiological investigations and thirteen experimental studies. Among the malignancies examined, thyroid cancer exhibited the most consistent positive association with BFR exposure, with decabromodiphenyl ether (BDE-209) identified as the principal contributor (odds ratio [OR] = 1.03–2.29 for BDE-209), whereas the evidence for breast and other cancers remained inconsistent. Experimental investigations elucidated several biologically plausible mechanisms, including oxidative stress, endocrine disruption, pro-inflammatory nuclear factor kappa B (NF-κB) signaling, and immune modulation. Conclusion: Collectively, the available evidence indicates that BFR exposure may elevate cancer risk, particularly for thyroid malignancy; nevertheless, the substantial heterogeneity across studies underscores the need for standardized exposure assessment, prospective cohort designs, and further mechanistic validation before definitive causal inferences can be established.
No takes yet. Share an insight, caveat, or question.
Lin et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: